Michael Chin, MD
Surgery · Riverside, CANPI 1114012648
Payments from drug & device makers
Across 101 payments — averaging $53.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Silk Road Medical, Inc.$743
- Acell, Inc.$453
- W. L. Gore & Associates, Inc.$260
- Elucent Medical$202
- Covidien LP$198
- plus $2K from 23 others
What the payments were for
- Travel & lodging$1,60330%
- Food & beverage$3,44864%
- Education$3787%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 23 | $1,776 |
| Silk Road Medical, Inc. | 16 | $743 |
| Acell, Inc. | 3 | $453 |
| W. L. Gore & Associates, Inc. | 3 | $260 |
| Elucent Medical | 1 | $202 |
| Covidien LP | 4 | $198 |
| Integra Lifesciences Corporation | 2 | $188 |
| Johnson & Johnson | 4 | $182 |
| TELA Bio, Inc. | 2 | $175 |
| Catheter Precision, Inc. FKA Ra Medical Systems, Inc. | 2 | $170 |
| Smith+Nephew | 16 | $161 |
| Bolton Medical Inc | 1 | $140 |
| Baxter Healthcare | 1 | $125 |
| Dilon Technologies, Inc. | 1 | $116 |
| Philips North America LLC | 5 | $91 |
| Intuitive Surgical | 1 | $84 |
| Lemaitre Vascular, Inc. | 1 | $66 |
| Abbott | 2 | $44 |
| Inspiremd Ltd | 1 | $35 |
| Boston Scientific | 1 | $33 |
| Bard Peripheral Vascular, Inc. | 2 | $32 |
| Getinge USA Sales, LLC | 1 | $31 |
| Novo Nordisk | 2 | $29 |
| Davol Inc. | 1 | $23 |
| Terumo Medical Corporation | 1 | $22 |
| Trevena, Inc. | 1 | $17 |
| Imperative Care, Inc | 1 | $16 |
| Biocompatibles, Inc. | 1 | $12 |
| Endogastric Solutions, Inc | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ellipsys$1,203
- INTEGRA$501
- ENROUTE Transcarotid Neuroprotection System$469
- ENROUTE Transcarotid Stent System$338
- ENHANCE Transcarotid Peripheral Access Kit$338
- ENROUTE 0.014 Guidewire$338
- INTEGRA DERMAL REGENERATION TEMPLATE$167
- PRIMATRIX$167
- Ovitex$148
- Relay Grafts$140
- ENROUTE Transcarotid Stent$132
- Renal - PD$125
- C3 Delivery System$124
- HemoBlast Bellows$116
How this compares
$5,430 in reported general payments places this provider in the 65th percentile of 2,363 surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 39 | $256 |
| Tramadol Hcl | 66 | $137 |
Paid to pharmacies, not to this prescriber.
Other surgery in Riverside
- Harvey NurickRiverside$243K
- Timothy ChuterSan Francisco$8.9M
- Peter StockSan Francisco$6.5M
- Santiago HorganSan Diego$2.8M
- Kenneth DeckLaguna Hills$2.4M
- Daniel RiskinSan Jose$2.2M
- Michael DemeureNewport Beach$1.7M
- Rock LiuHayward$1.6M
- David LouriePasadena$1.4M
- Andrea PakulaThousand Oaks$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.